HomeCWY0 • FRA
add
Clearmind Medicine Inc
Previous close
€0.85
Day range
€0.83 - €0.84
Year range
€0.78 - €1.95
Market cap
5.08M USD
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.50M | 8.11% |
Net income | -1.07M | 21.65% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.49M | -8.15% |
Effective tax rate | -3.81% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.92M | -36.88% |
Total assets | 6.58M | -34.79% |
Total liabilities | 3.73M | -26.20% |
Total equity | 2.85M | — |
Shares outstanding | 5.13M | — |
Price to book | 1.40 | — |
Return on assets | -54.05% | — |
Return on capital | -123.44% | — |
Cash Flow
Net change in cash
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -1.07M | 21.65% |
Cash from operations | -1.27M | 13.44% |
Cash from investing | 69.46K | — |
Cash from financing | 404.81K | -92.39% |
Net change in cash | -792.62K | -120.54% |
Free cash flow | -1.23M | -20.48% |
About
Founded
2017
Headquarters
Website
